Global Nivolumab Injection Market Research Report 2025(Status and Outlook)
Report Overview
Nivolumab injection is a monoclonal antibody medication used in immunotherapy to treat various cancers, including melanoma, non-small cell lung cancer, renal cell carcinoma, and Hodgkin lymphoma, by inhibiting the PD-1 protein and enhancing the immune system's ability to attack tumor cells.
The global market for Nivolumab has expanded significantly due to rising cancer prevalence, increasing demand for targeted therapies, and favorable regulatory approvals. Key drivers include advancements in immuno-oncology, strong clinical trial results demonstrating improved survival rates, and growing healthcare expenditure in emerging markets. However, high treatment costs and potential side effects such as immune-related adverse events pose challenges. Leading pharmaceutical companies, including Bristol-Myers Squibb (the original developer), face competition from other PD-1/PD-L1 inhibitors like pembrolizumab (Keytruda) and atezolizumab (Tecentriq). The market is also influenced by biosimilars entering the space, patent expirations, and strategic collaborations for combination therapies. Geographically, North America dominates due to robust oncology infrastructure, while Asia-Pacific shows rapid growth driven by increasing cancer awareness and improving healthcare access. Future trends include personalized medicine approaches, expanded indications, and cost-reduction strategies to improve affordability.
The global Nivolumab Injection market size was estimated at USD 1978.42 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Nivolumab Injection market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Nivolumab Injection market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Nivolumab Injection market.
Global Nivolumab Injection Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
AbbVie
Allergan
Ono Pharmaceutical
Sinopharm
Bristol-Myers Squibb
Market Segmentation (by Type)
100IU
50IU
Other
Market Segmentation (by Application)
Unresectable Melanoma
Metastatic Melanoma
Metastatic Squamous NSCLC
Classical Hodgkin Lymphoma
Renal Cell Carcinoma
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Nivolumab Injection Market
Overview of the regional outlook of the Nivolumab Injection Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Nivolumab Injection Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Nivolumab Injection, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Nivolumab injection is a monoclonal antibody medication used in immunotherapy to treat various cancers, including melanoma, non-small cell lung cancer, renal cell carcinoma, and Hodgkin lymphoma, by inhibiting the PD-1 protein and enhancing the immune system's ability to attack tumor cells.
The global market for Nivolumab has expanded significantly due to rising cancer prevalence, increasing demand for targeted therapies, and favorable regulatory approvals. Key drivers include advancements in immuno-oncology, strong clinical trial results demonstrating improved survival rates, and growing healthcare expenditure in emerging markets. However, high treatment costs and potential side effects such as immune-related adverse events pose challenges. Leading pharmaceutical companies, including Bristol-Myers Squibb (the original developer), face competition from other PD-1/PD-L1 inhibitors like pembrolizumab (Keytruda) and atezolizumab (Tecentriq). The market is also influenced by biosimilars entering the space, patent expirations, and strategic collaborations for combination therapies. Geographically, North America dominates due to robust oncology infrastructure, while Asia-Pacific shows rapid growth driven by increasing cancer awareness and improving healthcare access. Future trends include personalized medicine approaches, expanded indications, and cost-reduction strategies to improve affordability.
The global Nivolumab Injection market size was estimated at USD 1978.42 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Nivolumab Injection market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Nivolumab Injection market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Nivolumab Injection market.
Global Nivolumab Injection Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
AbbVie
Allergan
Ono Pharmaceutical
Sinopharm
Bristol-Myers Squibb
Market Segmentation (by Type)
100IU
50IU
Other
Market Segmentation (by Application)
Unresectable Melanoma
Metastatic Melanoma
Metastatic Squamous NSCLC
Classical Hodgkin Lymphoma
Renal Cell Carcinoma
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Nivolumab Injection Market
Overview of the regional outlook of the Nivolumab Injection Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Nivolumab Injection Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Nivolumab Injection, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Nivolumab Injection
1.2 Key Market Segments
1.2.1 Nivolumab Injection Segment by Type
1.2.2 Nivolumab Injection Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NIVOLUMAB INJECTION MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Nivolumab Injection Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Nivolumab Injection Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NIVOLUMAB INJECTION MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Nivolumab Injection Product Life Cycle
3.3 Global Nivolumab Injection Sales by Manufacturers (2020-2025)
3.4 Global Nivolumab Injection Revenue Market Share by Manufacturers (2020-2025)
3.5 Nivolumab Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Nivolumab Injection Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Nivolumab Injection Market Competitive Situation and Trends
3.8.1 Nivolumab Injection Market Concentration Rate
3.8.2 Global 5 and 10 Largest Nivolumab Injection Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 NIVOLUMAB INJECTION INDUSTRY CHAIN ANALYSIS
4.1 Nivolumab Injection Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NIVOLUMAB INJECTION MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Nivolumab Injection Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Nivolumab Injection Market
5.7 ESG Ratings of Leading Companies
6 NIVOLUMAB INJECTION MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Nivolumab Injection Sales Market Share by Type (2020-2025)
6.3 Global Nivolumab Injection Market Size Market Share by Type (2020-2025)
6.4 Global Nivolumab Injection Price by Type (2020-2025)
7 NIVOLUMAB INJECTION MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Nivolumab Injection Market Sales by Application (2020-2025)
7.3 Global Nivolumab Injection Market Size (M USD) by Application (2020-2025)
7.4 Global Nivolumab Injection Sales Growth Rate by Application (2020-2025)
8 NIVOLUMAB INJECTION MARKET SALES BY REGION
8.1 Global Nivolumab Injection Sales by Region
8.1.1 Global Nivolumab Injection Sales by Region
8.1.2 Global Nivolumab Injection Sales Market Share by Region
8.2 Global Nivolumab Injection Market Size by Region
8.2.1 Global Nivolumab Injection Market Size by Region
8.2.2 Global Nivolumab Injection Market Size Market Share by Region
8.3 North America
8.3.1 North America Nivolumab Injection Sales by Country
8.3.2 North America Nivolumab Injection Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Nivolumab Injection Sales by Country
8.4.2 Europe Nivolumab Injection Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Nivolumab Injection Sales by Region
8.5.2 Asia Pacific Nivolumab Injection Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Nivolumab Injection Sales by Country
8.6.2 South America Nivolumab Injection Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Nivolumab Injection Sales by Region
8.7.2 Middle East and Africa Nivolumab Injection Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 NIVOLUMAB INJECTION MARKET PRODUCTION BY REGION
9.1 Global Production of Nivolumab Injection by Region(2020-2025)
9.2 Global Nivolumab Injection Revenue Market Share by Region (2020-2025)
9.3 Global Nivolumab Injection Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Nivolumab Injection Production
9.4.1 North America Nivolumab Injection Production Growth Rate (2020-2025)
9.4.2 North America Nivolumab Injection Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Nivolumab Injection Production
9.5.1 Europe Nivolumab Injection Production Growth Rate (2020-2025)
9.5.2 Europe Nivolumab Injection Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Nivolumab Injection Production (2020-2025)
9.6.1 Japan Nivolumab Injection Production Growth Rate (2020-2025)
9.6.2 Japan Nivolumab Injection Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Nivolumab Injection Production (2020-2025)
9.7.1 China Nivolumab Injection Production Growth Rate (2020-2025)
9.7.2 China Nivolumab Injection Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 AbbVie
10.1.1 AbbVie Basic Information
10.1.2 AbbVie Nivolumab Injection Product Overview
10.1.3 AbbVie Nivolumab Injection Product Market Performance
10.1.4 AbbVie Business Overview
10.1.5 AbbVie SWOT Analysis
10.1.6 AbbVie Recent Developments
10.2 Allergan
10.2.1 Allergan Basic Information
10.2.2 Allergan Nivolumab Injection Product Overview
10.2.3 Allergan Nivolumab Injection Product Market Performance
10.2.4 Allergan Business Overview
10.2.5 Allergan SWOT Analysis
10.2.6 Allergan Recent Developments
10.3 Ono Pharmaceutical
10.3.1 Ono Pharmaceutical Basic Information
10.3.2 Ono Pharmaceutical Nivolumab Injection Product Overview
10.3.3 Ono Pharmaceutical Nivolumab Injection Product Market Performance
10.3.4 Ono Pharmaceutical Business Overview
10.3.5 Ono Pharmaceutical SWOT Analysis
10.3.6 Ono Pharmaceutical Recent Developments
10.4 Sinopharm
10.4.1 Sinopharm Basic Information
10.4.2 Sinopharm Nivolumab Injection Product Overview
10.4.3 Sinopharm Nivolumab Injection Product Market Performance
10.4.4 Sinopharm Business Overview
10.4.5 Sinopharm Recent Developments
10.5 Bristol-Myers Squibb
10.5.1 Bristol-Myers Squibb Basic Information
10.5.2 Bristol-Myers Squibb Nivolumab Injection Product Overview
10.5.3 Bristol-Myers Squibb Nivolumab Injection Product Market Performance
10.5.4 Bristol-Myers Squibb Business Overview
10.5.5 Bristol-Myers Squibb Recent Developments
11 NIVOLUMAB INJECTION MARKET FORECAST BY REGION
11.1 Global Nivolumab Injection Market Size Forecast
11.2 Global Nivolumab Injection Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Nivolumab Injection Market Size Forecast by Country
11.2.3 Asia Pacific Nivolumab Injection Market Size Forecast by Region
11.2.4 South America Nivolumab Injection Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Nivolumab Injection by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Nivolumab Injection Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Nivolumab Injection by Type (2026-2033)
12.1.2 Global Nivolumab Injection Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Nivolumab Injection by Type (2026-2033)
12.2 Global Nivolumab Injection Market Forecast by Application (2026-2033)
12.2.1 Global Nivolumab Injection Sales (K MT) Forecast by Application
12.2.2 Global Nivolumab Injection Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Nivolumab Injection
1.2 Key Market Segments
1.2.1 Nivolumab Injection Segment by Type
1.2.2 Nivolumab Injection Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NIVOLUMAB INJECTION MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Nivolumab Injection Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Nivolumab Injection Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NIVOLUMAB INJECTION MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Nivolumab Injection Product Life Cycle
3.3 Global Nivolumab Injection Sales by Manufacturers (2020-2025)
3.4 Global Nivolumab Injection Revenue Market Share by Manufacturers (2020-2025)
3.5 Nivolumab Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Nivolumab Injection Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Nivolumab Injection Market Competitive Situation and Trends
3.8.1 Nivolumab Injection Market Concentration Rate
3.8.2 Global 5 and 10 Largest Nivolumab Injection Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 NIVOLUMAB INJECTION INDUSTRY CHAIN ANALYSIS
4.1 Nivolumab Injection Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NIVOLUMAB INJECTION MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Nivolumab Injection Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Nivolumab Injection Market
5.7 ESG Ratings of Leading Companies
6 NIVOLUMAB INJECTION MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Nivolumab Injection Sales Market Share by Type (2020-2025)
6.3 Global Nivolumab Injection Market Size Market Share by Type (2020-2025)
6.4 Global Nivolumab Injection Price by Type (2020-2025)
7 NIVOLUMAB INJECTION MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Nivolumab Injection Market Sales by Application (2020-2025)
7.3 Global Nivolumab Injection Market Size (M USD) by Application (2020-2025)
7.4 Global Nivolumab Injection Sales Growth Rate by Application (2020-2025)
8 NIVOLUMAB INJECTION MARKET SALES BY REGION
8.1 Global Nivolumab Injection Sales by Region
8.1.1 Global Nivolumab Injection Sales by Region
8.1.2 Global Nivolumab Injection Sales Market Share by Region
8.2 Global Nivolumab Injection Market Size by Region
8.2.1 Global Nivolumab Injection Market Size by Region
8.2.2 Global Nivolumab Injection Market Size Market Share by Region
8.3 North America
8.3.1 North America Nivolumab Injection Sales by Country
8.3.2 North America Nivolumab Injection Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Nivolumab Injection Sales by Country
8.4.2 Europe Nivolumab Injection Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Nivolumab Injection Sales by Region
8.5.2 Asia Pacific Nivolumab Injection Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Nivolumab Injection Sales by Country
8.6.2 South America Nivolumab Injection Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Nivolumab Injection Sales by Region
8.7.2 Middle East and Africa Nivolumab Injection Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 NIVOLUMAB INJECTION MARKET PRODUCTION BY REGION
9.1 Global Production of Nivolumab Injection by Region(2020-2025)
9.2 Global Nivolumab Injection Revenue Market Share by Region (2020-2025)
9.3 Global Nivolumab Injection Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Nivolumab Injection Production
9.4.1 North America Nivolumab Injection Production Growth Rate (2020-2025)
9.4.2 North America Nivolumab Injection Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Nivolumab Injection Production
9.5.1 Europe Nivolumab Injection Production Growth Rate (2020-2025)
9.5.2 Europe Nivolumab Injection Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Nivolumab Injection Production (2020-2025)
9.6.1 Japan Nivolumab Injection Production Growth Rate (2020-2025)
9.6.2 Japan Nivolumab Injection Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Nivolumab Injection Production (2020-2025)
9.7.1 China Nivolumab Injection Production Growth Rate (2020-2025)
9.7.2 China Nivolumab Injection Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 AbbVie
10.1.1 AbbVie Basic Information
10.1.2 AbbVie Nivolumab Injection Product Overview
10.1.3 AbbVie Nivolumab Injection Product Market Performance
10.1.4 AbbVie Business Overview
10.1.5 AbbVie SWOT Analysis
10.1.6 AbbVie Recent Developments
10.2 Allergan
10.2.1 Allergan Basic Information
10.2.2 Allergan Nivolumab Injection Product Overview
10.2.3 Allergan Nivolumab Injection Product Market Performance
10.2.4 Allergan Business Overview
10.2.5 Allergan SWOT Analysis
10.2.6 Allergan Recent Developments
10.3 Ono Pharmaceutical
10.3.1 Ono Pharmaceutical Basic Information
10.3.2 Ono Pharmaceutical Nivolumab Injection Product Overview
10.3.3 Ono Pharmaceutical Nivolumab Injection Product Market Performance
10.3.4 Ono Pharmaceutical Business Overview
10.3.5 Ono Pharmaceutical SWOT Analysis
10.3.6 Ono Pharmaceutical Recent Developments
10.4 Sinopharm
10.4.1 Sinopharm Basic Information
10.4.2 Sinopharm Nivolumab Injection Product Overview
10.4.3 Sinopharm Nivolumab Injection Product Market Performance
10.4.4 Sinopharm Business Overview
10.4.5 Sinopharm Recent Developments
10.5 Bristol-Myers Squibb
10.5.1 Bristol-Myers Squibb Basic Information
10.5.2 Bristol-Myers Squibb Nivolumab Injection Product Overview
10.5.3 Bristol-Myers Squibb Nivolumab Injection Product Market Performance
10.5.4 Bristol-Myers Squibb Business Overview
10.5.5 Bristol-Myers Squibb Recent Developments
11 NIVOLUMAB INJECTION MARKET FORECAST BY REGION
11.1 Global Nivolumab Injection Market Size Forecast
11.2 Global Nivolumab Injection Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Nivolumab Injection Market Size Forecast by Country
11.2.3 Asia Pacific Nivolumab Injection Market Size Forecast by Region
11.2.4 South America Nivolumab Injection Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Nivolumab Injection by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Nivolumab Injection Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Nivolumab Injection by Type (2026-2033)
12.1.2 Global Nivolumab Injection Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Nivolumab Injection by Type (2026-2033)
12.2 Global Nivolumab Injection Market Forecast by Application (2026-2033)
12.2.1 Global Nivolumab Injection Sales (K MT) Forecast by Application
12.2.2 Global Nivolumab Injection Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Nivolumab Injection Market Size Comparison by Region (M USD)
Table 5. Global Nivolumab Injection Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Nivolumab Injection Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Nivolumab Injection Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Nivolumab Injection Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nivolumab Injection as of 2024)
Table 10. Global Market Nivolumab Injection Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Nivolumab Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Nivolumab Injection Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Nivolumab Injection Sales by Type (K MT)
Table 26. Global Nivolumab Injection Market Size by Type (M USD)
Table 27. Global Nivolumab Injection Sales (K MT) by Type (2020-2025)
Table 28. Global Nivolumab Injection Sales Market Share by Type (2020-2025)
Table 29. Global Nivolumab Injection Market Size (M USD) by Type (2020-2025)
Table 30. Global Nivolumab Injection Market Size Share by Type (2020-2025)
Table 31. Global Nivolumab Injection Price (USD/KG) by Type (2020-2025)
Table 32. Global Nivolumab Injection Sales (K MT) by Application
Table 33. Global Nivolumab Injection Market Size by Application
Table 34. Global Nivolumab Injection Sales by Application (2020-2025) & (K MT)
Table 35. Global Nivolumab Injection Sales Market Share by Application (2020-2025)
Table 36. Global Nivolumab Injection Market Size by Application (2020-2025) & (M USD)
Table 37. Global Nivolumab Injection Market Share by Application (2020-2025)
Table 38. Global Nivolumab Injection Sales Growth Rate by Application (2020-2025)
Table 39. Global Nivolumab Injection Sales by Region (2020-2025) & (K MT)
Table 40. Global Nivolumab Injection Sales Market Share by Region (2020-2025)
Table 41. Global Nivolumab Injection Market Size by Region (2020-2025) & (M USD)
Table 42. Global Nivolumab Injection Market Size Market Share by Region (2020-2025)
Table 43. North America Nivolumab Injection Sales by Country (2020-2025) & (K MT)
Table 44. North America Nivolumab Injection Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Nivolumab Injection Sales by Country (2020-2025) & (K MT)
Table 46. Europe Nivolumab Injection Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Nivolumab Injection Sales by Region (2020-2025) & (K MT)
Table 48. Asia Pacific Nivolumab Injection Market Size by Region (2020-2025) & (M USD)
Table 49. South America Nivolumab Injection Sales by Country (2020-2025) & (K MT)
Table 50. South America Nivolumab Injection Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Nivolumab Injection Sales by Region (2020-2025) & (K MT)
Table 52. Middle East and Africa Nivolumab Injection Market Size by Region (2020-2025) & (M USD)
Table 53. Global Nivolumab Injection Production (K MT) by Region(2020-2025)
Table 54. Global Nivolumab Injection Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Nivolumab Injection Revenue Market Share by Region (2020-2025)
Table 56. Global Nivolumab Injection Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 57. North America Nivolumab Injection Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. Europe Nivolumab Injection Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Japan Nivolumab Injection Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. China Nivolumab Injection Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. AbbVie Basic Information
Table 62. AbbVie Nivolumab Injection Product Overview
Table 63. AbbVie Nivolumab Injection Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 64. AbbVie Business Overview
Table 65. AbbVie SWOT Analysis
Table 66. AbbVie Recent Developments
Table 67. Allergan Basic Information
Table 68. Allergan Nivolumab Injection Product Overview
Table 69. Allergan Nivolumab Injection Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 70. Allergan Business Overview
Table 71. Allergan SWOT Analysis
Table 72. Allergan Recent Developments
Table 73. Ono Pharmaceutical Basic Information
Table 74. Ono Pharmaceutical Nivolumab Injection Product Overview
Table 75. Ono Pharmaceutical Nivolumab Injection Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 76. Ono Pharmaceutical Business Overview
Table 77. Ono Pharmaceutical SWOT Analysis
Table 78. Ono Pharmaceutical Recent Developments
Table 79. Sinopharm Basic Information
Table 80. Sinopharm Nivolumab Injection Product Overview
Table 81. Sinopharm Nivolumab Injection Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 82. Sinopharm Business Overview
Table 83. Sinopharm Recent Developments
Table 84. Bristol-Myers Squibb Basic Information
Table 85. Bristol-Myers Squibb Nivolumab Injection Product Overview
Table 86. Bristol-Myers Squibb Nivolumab Injection Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 87. Bristol-Myers Squibb Business Overview
Table 88. Bristol-Myers Squibb Recent Developments
Table 89. Global Nivolumab Injection Sales Forecast by Region (2026-2033) & (K MT)
Table 90. Global Nivolumab Injection Market Size Forecast by Region (2026-2033) & (M USD)
Table 91. North America Nivolumab Injection Sales Forecast by Country (2026-2033) & (K MT)
Table 92. North America Nivolumab Injection Market Size Forecast by Country (2026-2033) & (M USD)
Table 93. Europe Nivolumab Injection Sales Forecast by Country (2026-2033) & (K MT)
Table 94. Europe Nivolumab Injection Market Size Forecast by Country (2026-2033) & (M USD)
Table 95. Asia Pacific Nivolumab Injection Sales Forecast by Region (2026-2033) & (K MT)
Table 96. Asia Pacific Nivolumab Injection Market Size Forecast by Region (2026-2033) & (M USD)
Table 97. South America Nivolumab Injection Sales Forecast by Country (2026-2033) & (K MT)
Table 98. South America Nivolumab Injection Market Size Forecast by Country (2026-2033) & (M USD)
Table 99. Middle East and Africa Nivolumab Injection Sales Forecast by Country (2026-2033) & (Units)
Table 100. Middle East and Africa Nivolumab Injection Market Size Forecast by Country (2026-2033) & (M USD)
Table 101. Global Nivolumab Injection Sales Forecast by Type (2026-2033) & (K MT)
Table 102. Global Nivolumab Injection Market Size Forecast by Type (2026-2033) & (M USD)
Table 103. Global Nivolumab Injection Price Forecast by Type (2026-2033) & (USD/KG)
Table 104. Global Nivolumab Injection Sales (K MT) Forecast by Application (2026-2033)
Table 105. Global Nivolumab Injection Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Nivolumab Injection Market Size Comparison by Region (M USD)
Table 5. Global Nivolumab Injection Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Nivolumab Injection Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Nivolumab Injection Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Nivolumab Injection Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nivolumab Injection as of 2024)
Table 10. Global Market Nivolumab Injection Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Nivolumab Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Nivolumab Injection Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Nivolumab Injection Sales by Type (K MT)
Table 26. Global Nivolumab Injection Market Size by Type (M USD)
Table 27. Global Nivolumab Injection Sales (K MT) by Type (2020-2025)
Table 28. Global Nivolumab Injection Sales Market Share by Type (2020-2025)
Table 29. Global Nivolumab Injection Market Size (M USD) by Type (2020-2025)
Table 30. Global Nivolumab Injection Market Size Share by Type (2020-2025)
Table 31. Global Nivolumab Injection Price (USD/KG) by Type (2020-2025)
Table 32. Global Nivolumab Injection Sales (K MT) by Application
Table 33. Global Nivolumab Injection Market Size by Application
Table 34. Global Nivolumab Injection Sales by Application (2020-2025) & (K MT)
Table 35. Global Nivolumab Injection Sales Market Share by Application (2020-2025)
Table 36. Global Nivolumab Injection Market Size by Application (2020-2025) & (M USD)
Table 37. Global Nivolumab Injection Market Share by Application (2020-2025)
Table 38. Global Nivolumab Injection Sales Growth Rate by Application (2020-2025)
Table 39. Global Nivolumab Injection Sales by Region (2020-2025) & (K MT)
Table 40. Global Nivolumab Injection Sales Market Share by Region (2020-2025)
Table 41. Global Nivolumab Injection Market Size by Region (2020-2025) & (M USD)
Table 42. Global Nivolumab Injection Market Size Market Share by Region (2020-2025)
Table 43. North America Nivolumab Injection Sales by Country (2020-2025) & (K MT)
Table 44. North America Nivolumab Injection Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Nivolumab Injection Sales by Country (2020-2025) & (K MT)
Table 46. Europe Nivolumab Injection Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Nivolumab Injection Sales by Region (2020-2025) & (K MT)
Table 48. Asia Pacific Nivolumab Injection Market Size by Region (2020-2025) & (M USD)
Table 49. South America Nivolumab Injection Sales by Country (2020-2025) & (K MT)
Table 50. South America Nivolumab Injection Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Nivolumab Injection Sales by Region (2020-2025) & (K MT)
Table 52. Middle East and Africa Nivolumab Injection Market Size by Region (2020-2025) & (M USD)
Table 53. Global Nivolumab Injection Production (K MT) by Region(2020-2025)
Table 54. Global Nivolumab Injection Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Nivolumab Injection Revenue Market Share by Region (2020-2025)
Table 56. Global Nivolumab Injection Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 57. North America Nivolumab Injection Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. Europe Nivolumab Injection Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Japan Nivolumab Injection Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. China Nivolumab Injection Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. AbbVie Basic Information
Table 62. AbbVie Nivolumab Injection Product Overview
Table 63. AbbVie Nivolumab Injection Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 64. AbbVie Business Overview
Table 65. AbbVie SWOT Analysis
Table 66. AbbVie Recent Developments
Table 67. Allergan Basic Information
Table 68. Allergan Nivolumab Injection Product Overview
Table 69. Allergan Nivolumab Injection Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 70. Allergan Business Overview
Table 71. Allergan SWOT Analysis
Table 72. Allergan Recent Developments
Table 73. Ono Pharmaceutical Basic Information
Table 74. Ono Pharmaceutical Nivolumab Injection Product Overview
Table 75. Ono Pharmaceutical Nivolumab Injection Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 76. Ono Pharmaceutical Business Overview
Table 77. Ono Pharmaceutical SWOT Analysis
Table 78. Ono Pharmaceutical Recent Developments
Table 79. Sinopharm Basic Information
Table 80. Sinopharm Nivolumab Injection Product Overview
Table 81. Sinopharm Nivolumab Injection Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 82. Sinopharm Business Overview
Table 83. Sinopharm Recent Developments
Table 84. Bristol-Myers Squibb Basic Information
Table 85. Bristol-Myers Squibb Nivolumab Injection Product Overview
Table 86. Bristol-Myers Squibb Nivolumab Injection Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 87. Bristol-Myers Squibb Business Overview
Table 88. Bristol-Myers Squibb Recent Developments
Table 89. Global Nivolumab Injection Sales Forecast by Region (2026-2033) & (K MT)
Table 90. Global Nivolumab Injection Market Size Forecast by Region (2026-2033) & (M USD)
Table 91. North America Nivolumab Injection Sales Forecast by Country (2026-2033) & (K MT)
Table 92. North America Nivolumab Injection Market Size Forecast by Country (2026-2033) & (M USD)
Table 93. Europe Nivolumab Injection Sales Forecast by Country (2026-2033) & (K MT)
Table 94. Europe Nivolumab Injection Market Size Forecast by Country (2026-2033) & (M USD)
Table 95. Asia Pacific Nivolumab Injection Sales Forecast by Region (2026-2033) & (K MT)
Table 96. Asia Pacific Nivolumab Injection Market Size Forecast by Region (2026-2033) & (M USD)
Table 97. South America Nivolumab Injection Sales Forecast by Country (2026-2033) & (K MT)
Table 98. South America Nivolumab Injection Market Size Forecast by Country (2026-2033) & (M USD)
Table 99. Middle East and Africa Nivolumab Injection Sales Forecast by Country (2026-2033) & (Units)
Table 100. Middle East and Africa Nivolumab Injection Market Size Forecast by Country (2026-2033) & (M USD)
Table 101. Global Nivolumab Injection Sales Forecast by Type (2026-2033) & (K MT)
Table 102. Global Nivolumab Injection Market Size Forecast by Type (2026-2033) & (M USD)
Table 103. Global Nivolumab Injection Price Forecast by Type (2026-2033) & (USD/KG)
Table 104. Global Nivolumab Injection Sales (K MT) Forecast by Application (2026-2033)
Table 105. Global Nivolumab Injection Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Nivolumab Injection
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Nivolumab Injection Market Size (M USD), 2024-2033
Figure 5. Global Nivolumab Injection Market Size (M USD) (2020-2033)
Figure 6. Global Nivolumab Injection Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Nivolumab Injection Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Nivolumab Injection Product Life Cycle
Figure 13. Nivolumab Injection Sales Share by Manufacturers in 2024
Figure 14. Global Nivolumab Injection Revenue Share by Manufacturers in 2024
Figure 15. Nivolumab Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Nivolumab Injection Average Price (USD/KG) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Nivolumab Injection Revenue in 2024
Figure 18. Industry Chain Map of Nivolumab Injection
Figure 19. Global Nivolumab Injection Market PEST Analysis
Figure 20. Global Nivolumab Injection Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Nivolumab Injection Market Share by Type
Figure 27. Sales Market Share of Nivolumab Injection by Type (2020-2025)
Figure 28. Sales Market Share of Nivolumab Injection by Type in 2024
Figure 29. Market Size Share of Nivolumab Injection by Type (2020-2025)
Figure 30. Market Size Share of Nivolumab Injection by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Nivolumab Injection Market Share by Application
Figure 33. Global Nivolumab Injection Sales Market Share by Application (2020-2025)
Figure 34. Global Nivolumab Injection Sales Market Share by Application in 2024
Figure 35. Global Nivolumab Injection Market Share by Application (2020-2025)
Figure 36. Global Nivolumab Injection Market Share by Application in 2024
Figure 37. Global Nivolumab Injection Sales Growth Rate by Application (2020-2025)
Figure 38. Global Nivolumab Injection Sales Market Share by Region (2020-2025)
Figure 39. Global Nivolumab Injection Market Size Market Share by Region (2020-2025)
Figure 40. North America Nivolumab Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Nivolumab Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Nivolumab Injection Sales Market Share by Country in 2024
Figure 43. North America Nivolumab Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Nivolumab Injection Market Size Market Share by Country in 2024
Figure 45. U.S. Nivolumab Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Nivolumab Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Nivolumab Injection Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Nivolumab Injection Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Nivolumab Injection Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Nivolumab Injection Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Nivolumab Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Nivolumab Injection Sales Market Share by Country in 2024
Figure 53. Europe Nivolumab Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Nivolumab Injection Market Size Market Share by Country in 2024
Figure 55. Germany Nivolumab Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Nivolumab Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Nivolumab Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Nivolumab Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Nivolumab Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Nivolumab Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Nivolumab Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Nivolumab Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Nivolumab Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Nivolumab Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Nivolumab Injection Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Nivolumab Injection Sales Market Share by Region in 2024
Figure 67. Asia Pacific Nivolumab Injection Market Size Market Share by Region in 2024
Figure 68. China Nivolumab Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Nivolumab Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Nivolumab Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Nivolumab Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Nivolumab Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Nivolumab Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Nivolumab Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Nivolumab Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Nivolumab Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Nivolumab Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Nivolumab Injection Sales and Growth Rate (K MT)
Figure 79. South America Nivolumab Injection Sales Market Share by Country in 2024
Figure 80. South America Nivolumab Injection Market Size and Growth Rate (M USD)
Figure 81. South America Nivolumab Injection Market Size Market Share by Country in 2024
Figure 82. Brazil Nivolumab Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Nivolumab Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Nivolumab Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Nivolumab Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Nivolumab Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Nivolumab Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Nivolumab Injection Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Nivolumab Injection Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Nivolumab Injection Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Nivolumab Injection Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Nivolumab Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Nivolumab Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Nivolumab Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Nivolumab Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Nivolumab Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Nivolumab Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Nivolumab Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Nivolumab Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Nivolumab Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Nivolumab Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Nivolumab Injection Production Market Share by Region (2020-2025)
Figure 103. North America Nivolumab Injection Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Nivolumab Injection Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Nivolumab Injection Production (K MT) Growth Rate (2020-2025)
Figure 106. China Nivolumab Injection Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Nivolumab Injection Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Nivolumab Injection Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Nivolumab Injection Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Nivolumab Injection Market Share Forecast by Type (2026-2033)
Figure 111. Global Nivolumab Injection Sales Forecast by Application (2026-2033)
Figure 112. Global Nivolumab Injection Market Share Forecast by Application (2026-2033)
Figure 1. Product Picture of Nivolumab Injection
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Nivolumab Injection Market Size (M USD), 2024-2033
Figure 5. Global Nivolumab Injection Market Size (M USD) (2020-2033)
Figure 6. Global Nivolumab Injection Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Nivolumab Injection Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Nivolumab Injection Product Life Cycle
Figure 13. Nivolumab Injection Sales Share by Manufacturers in 2024
Figure 14. Global Nivolumab Injection Revenue Share by Manufacturers in 2024
Figure 15. Nivolumab Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Nivolumab Injection Average Price (USD/KG) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Nivolumab Injection Revenue in 2024
Figure 18. Industry Chain Map of Nivolumab Injection
Figure 19. Global Nivolumab Injection Market PEST Analysis
Figure 20. Global Nivolumab Injection Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Nivolumab Injection Market Share by Type
Figure 27. Sales Market Share of Nivolumab Injection by Type (2020-2025)
Figure 28. Sales Market Share of Nivolumab Injection by Type in 2024
Figure 29. Market Size Share of Nivolumab Injection by Type (2020-2025)
Figure 30. Market Size Share of Nivolumab Injection by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Nivolumab Injection Market Share by Application
Figure 33. Global Nivolumab Injection Sales Market Share by Application (2020-2025)
Figure 34. Global Nivolumab Injection Sales Market Share by Application in 2024
Figure 35. Global Nivolumab Injection Market Share by Application (2020-2025)
Figure 36. Global Nivolumab Injection Market Share by Application in 2024
Figure 37. Global Nivolumab Injection Sales Growth Rate by Application (2020-2025)
Figure 38. Global Nivolumab Injection Sales Market Share by Region (2020-2025)
Figure 39. Global Nivolumab Injection Market Size Market Share by Region (2020-2025)
Figure 40. North America Nivolumab Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Nivolumab Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Nivolumab Injection Sales Market Share by Country in 2024
Figure 43. North America Nivolumab Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Nivolumab Injection Market Size Market Share by Country in 2024
Figure 45. U.S. Nivolumab Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Nivolumab Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Nivolumab Injection Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Nivolumab Injection Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Nivolumab Injection Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Nivolumab Injection Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Nivolumab Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Nivolumab Injection Sales Market Share by Country in 2024
Figure 53. Europe Nivolumab Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Nivolumab Injection Market Size Market Share by Country in 2024
Figure 55. Germany Nivolumab Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Nivolumab Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Nivolumab Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Nivolumab Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Nivolumab Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Nivolumab Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Nivolumab Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Nivolumab Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Nivolumab Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Nivolumab Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Nivolumab Injection Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Nivolumab Injection Sales Market Share by Region in 2024
Figure 67. Asia Pacific Nivolumab Injection Market Size Market Share by Region in 2024
Figure 68. China Nivolumab Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Nivolumab Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Nivolumab Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Nivolumab Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Nivolumab Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Nivolumab Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Nivolumab Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Nivolumab Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Nivolumab Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Nivolumab Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Nivolumab Injection Sales and Growth Rate (K MT)
Figure 79. South America Nivolumab Injection Sales Market Share by Country in 2024
Figure 80. South America Nivolumab Injection Market Size and Growth Rate (M USD)
Figure 81. South America Nivolumab Injection Market Size Market Share by Country in 2024
Figure 82. Brazil Nivolumab Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Nivolumab Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Nivolumab Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Nivolumab Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Nivolumab Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Nivolumab Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Nivolumab Injection Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Nivolumab Injection Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Nivolumab Injection Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Nivolumab Injection Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Nivolumab Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Nivolumab Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Nivolumab Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Nivolumab Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Nivolumab Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Nivolumab Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Nivolumab Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Nivolumab Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Nivolumab Injection Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Nivolumab Injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Nivolumab Injection Production Market Share by Region (2020-2025)
Figure 103. North America Nivolumab Injection Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Nivolumab Injection Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Nivolumab Injection Production (K MT) Growth Rate (2020-2025)
Figure 106. China Nivolumab Injection Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Nivolumab Injection Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Nivolumab Injection Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Nivolumab Injection Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Nivolumab Injection Market Share Forecast by Type (2026-2033)
Figure 111. Global Nivolumab Injection Sales Forecast by Application (2026-2033)
Figure 112. Global Nivolumab Injection Market Share Forecast by Application (2026-2033)
More Publications
Global Soliris Intravenous Market Research Report 2025(Status and Outlook)
US$ 3,200.00
August 2025
79 pages
Global Medical Device Market Research Report 2022(Status and Outlook)
US$ 2,800.00
June 2022
150 pages
Global Capnography Equipment Market Research Report 2025(Status and Outlook)
US$ 3,200.00
August 2025
141 pages
Global Elapegademase lvlr Market Research Report 2025(Status and Outlook)
US$ 3,200.00
July 2025
120 pages
Global Companion Animal Specialty Drugs Market Research Report 2026(Status and Outlook)
US$ 3,200.00
May 2026
139 pages
